NIH Offers Commercialization Assistance Program to SBIR Phase II Awardees

As posted on U.S. Department of Health & Human Services Website, 8/27/09 

NIH announces the availability of a Commercialization Assistance Program (CAP) for its SBIR Phase II awardees from the past six years. Now in its sixth year, this program is designed to help NIH SBIR Phase II awardees transition their SBIR-developed products into the marketplace. The program includes two distinctive tracks that offer customized assistance for both early stage and seasoned companies: Commercialization Training Track and Accelerator Commercialization Track. For details, check the NIH Guide Notice NOT-OD-09-145 and also review the full program description at